Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients-Reference-Cited by-同舟云学术

Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients

Published:2016-07-17 Issue:11 Volume:71 Page:3235-3241
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Pradat Pierre,Durant Jacques,Brochier Corinne,Trabaud Mary-Anne,Cottalorda-Dufayard Jacqueline,Izopet Jacques,Raffi François,Lucht Frédéric,Gagnieu Marie-Claude,Gatey Caroline,Jacomet Christine,Vassallo Matteo,Dellamonica Pierre,Cotte Laurent

Funder

ViiV Healthcare and MSD

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/11/3235/16864005/dkw273.pdf

Reference26 articles.

1. European AIDS Clinical Society. Guidelines. Version 8.0, October 2015. Available at: http://www.eacsociety.org/files/2015_eacsguidelines_8.0-english_revised-20151104.pdf .

2. Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis

3. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis;Islam;HIV Med,2012

4. Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1

5. Long-term efficacy and safety of raltegravir in the management of HIV infection;Liedtke;Infect Drug Resist,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simplifying HAART: the Role of Two-Drug Therapy;Current Treatment Options in Infectious Diseases;2017-05-06